Zoetis will make Canine Atopic Dermatitis Immunotherapeutic* available primarily to veterinary dermatology specialists early in the fourth quarter of 2015 to gain more experience with this first ...
MSD Animal Health has presented new clinical trial data showing its oral drug NUMELVI® (atinvicitinib) significantly reduces itching and skin inflammation in dogs with atopic and allergic dermatitis.
The only JAK inhibitor approved in the U.S. for the control of pruritus associated with allergic dermatitis in dogs six months of age and older RAHWAY, N.J.--(BUSINESS WIRE)-- Merck Animal Health, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results